WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aquestive Therapeutics earnings were -$44.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AQST earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$17.1M, up 48.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AQST reported annual earnings of -$44.1M, with 460.8% growth. The next AQST earnings date is May 5, 2025.

AQST earnings history

Current Revenue
$57.6M
Current Earnings
-$44.1M
Current Profit Margin
-76.7%

AQST Return on Equity

Insufficient data to display

AQST undefined

Current Company
-38.5%
Current Industry
5.5%
AQST is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AQST announces earnings.

AQST undefined

Current Company
-33.11%
Current Industry
12%
AQST has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AQST vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AQST-$26.62M-$44.14MN/A-$0.51
EBS$36.90M-$190.60MN/A-$3.60
ACB$18.57M-$15.26MN/A-$3.00
LFCR-$14.23M-$49.40MN/A-$1.48
TKNO-$19.39M-$26.75MN/A-$0.57
View Top Pharmaceutical Stocks

AQST earnings dates

Next earnings date
May 5, 2025

Aquestive Therapeutics Earnings Reports & History FAQ

What were Aquestive Therapeutics's earnings last quarter?

On AQST's earnings call on Invalid Date, Aquestive Therapeutics (NASDAQ: AQST) reported Q4 2024 earnings per share (EPS) of -$0.19, up 46.15% year over year. Total AQST earnings for the quarter were -$17.06 million. In the same quarter last year, Aquestive Therapeutics's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.

When does Aquestive Therapeutics report earnings?

The next AQST earnings date is Invalid Date. Add AQST to your watchlist to be reminded of Aquestive Therapeutics's next earnings date.

Is Aquestive Therapeutics profitable or losing money?

As of the last Aquestive Therapeutics earnings report, Aquestive Therapeutics is currently losing money. Aquestive Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$44.14 million, a 460.83% increase year over year.

What was AQST's earnings growth in the past year?

As of Aquestive Therapeutics's earnings date in Invalid Date, Aquestive Therapeutics's earnings has grown year over year. AQST earnings in the past year totalled -$44.14 million.

What are Aquestive Therapeutics's earnings expectations?

The current EPS estimate for Aquestive Therapeutics's earnings report in Invalid Date is -$0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.